HRIA
IMGN

Haberer Registered Investment Advisor’s Immunogen Inc IMGN Stock Holding History

Haberer Registered Investment Advisor’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-600
Closed -$10K – 522
2013
Q2 		$10K Buy
+600
New +$9.72K ﹤0.01% 337

Other funds holding IMGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Haberer Registered Investment Advisor's IMGN Position: Q3 2013 in Review

Haberer Registered Investment Advisor sold out of Immunogen Inc (IMGN) in Q3 2013, closing a stake of 600 shares — an estimated $10K sold.

Haberer Registered Investment Advisor first reported a position in IMGN in Q2 2013 and held it in 1 quarter. The position peaked at $10K in Q2 2013. 141 funds tracked by Wall St. Rank hold IMGN as of Q3 2013.

  • Haberer Registered Investment Advisor reported no remaining Immunogen Inc position as of Q3 2013 after selling out during the quarter.
  • Haberer Registered Investment Advisor sold 600 Immunogen Inc shares in Q3 2013, an estimated $10K.
  • Haberer Registered Investment Advisor first reported a position in Immunogen Inc in Q2 2013 and held it in 1 quarter.
  • Haberer Registered Investment Advisor's Immunogen Inc position peaked at $10K in Q2 2013.
  • 141 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2013.

Based on Haberer Registered Investment Advisor's 13F filing for Q3 2013, filed 4 Oct 2013.